GP-Act III Acquisition Corp. (GPAT) Stock Score, Valuation & Financial Research

GP-Act III Acquisition Corp. is in the Financial Services sector and Shell Companies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for GPAT

GP-Act III Acquisition Corp. does not currently have a complete Wall Street Score. The stored market price is USD 11.02. These figures are a research snapshot, not a buy or sell recommendation.

What GP-Act III Acquisition Corp. does

GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. The company was incorporated in 2020 and is based in New York, New York.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

GP-Act III Acquisition Corp. is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company does not generate operating revenue and relies on funds held in a trust account and capital contributions from its sponsor to cover operating expenses and search for a target business.

Products and services

  • The company is a special purpose acquisition company (SPAC) that does not offer commercial products or services; its primary activity is identifying and consummating a business combination.

Suppliers, materials and equipment

  • GP-Act III Sponsor LLC — The company's sponsor, which provides financial support and working capital loans to cover operating expenses. Source

Business relationships and partnerships

  • Continental Stock Transfer & Trust Company — Acts as the trustee for the company's trust account and provides services related to the administration of the company's securities and trust assets. Source

Business risks and research considerations

  • The company has no operating history and no revenues, and there is no assurance that it will be able to successfully consummate a business combination. Source
  • The company is dependent upon its sponsor and officers to identify a suitable target business and may face conflicts of interest. Source

Sources: Company research source · Continental Stock Transfer & Trust Company

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

GPAT financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 11.02
Market capitalization:
396.03M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD 8.44M
Free cash flow:
USD -372.23K
Cash:
USD 10.59K
Total debt:
USD 595K
EPS:
USD 0.24
P/E ratio:
45.5x

What stands out

  • Free cash flow is USD -372.23K, negative for the stored period.
  • The balance sheet shows USD 10.59K of cash versus USD 595K of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a fundamental change risk warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Debt exceeds cash by USD 584.41K using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for GPAT

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can GPAT fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • Is GPAT's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What does the current fundamental change risk warning mean for the reliability or interpretation of GPAT's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 73% of the scoring inputs required for this public page are currently available.

How to research GPAT

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.